Brand Name
Coxanto
Generic Name
Oxaprozin
View Brand Information FDA approval date: January 31, 2001
Classification: Nonsteroidal Anti-inflammatory Drug
Form: Tablet, Capsule
What is Coxanto (Oxaprozin)?
COXANTO is indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis COXANTO is a non-steroidal anti-inflammatory drug indicated for: Relief of signs and symptoms of Osteoarthritis Relief of signs and symptoms of Rheumatoid Arthritis Relief of signs and symptoms of Juvenile Rheumatoid Arthritis
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment